These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 94908)

  • 41. The virus-induced signaling adaptor molecule enhances DNA-raised immune protection against H5N1 influenza virus infection in mice.
    Luo M; Qu X; Pan R; Zhu D; Zhang Y; Wu J; Pan Z
    Vaccine; 2011 Mar; 29(14):2561-7. PubMed ID: 21303708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intranasally administered Endocine formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets.
    Maltais AK; Stittelaar KJ; Veldhuis Kroeze EJ; van Amerongen G; Dijkshoorn ML; Krestin GP; Hinkula J; Arwidsson H; Lindberg A; Osterhaus AD
    Vaccine; 2014 May; 32(26):3307-15. PubMed ID: 24690149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Attempted induction of interferon by bacterial vaccines in allergic and nonallergic humans.
    Johnstone DE; Douglas RG; Simon R
    Ann Allergy; 1974 Feb; 32(2):70-2. PubMed ID: 4149323
    [No Abstract]   [Full Text] [Related]  

  • 44. [Antigenic similarity between polysaccharide and ribosomal vaccine extracts from Klebsiella pneumonia].
    Robert D; Lafont S; Bienvenu P; Normier G; Dussourd D'Hinterland L; Fontanges R
    C R Seances Acad Sci III; 1981 Jan; 292(3):281-4. PubMed ID: 6162585
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effectiveness of intranasal immunization with Myxovirus influenzae neuraminidase in mice].
    Bottex C; Robert D; Fontanges R
    C R Acad Hebd Seances Acad Sci D; 1977 May; 284(19):1943-6. PubMed ID: 69501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Murine Cross-Reactive Nonneutralizing Polyclonal IgG1 Antibodies Induced by Influenza Vaccine Inhibit the Cross-Protective Effect of IgG2 against Heterologous Virus in Mice.
    Shibuya M; Aoshi T; Kuroda E; Yoshioka Y
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP) as mucosal adjuvant to induce protective immunity against respiratory pathogens.
    Shim DH; Ko HJ; Volker G; Potter AA; Mutwiri G; Babiuk LA; Kweon MN
    Vaccine; 2010 Mar; 28(11):2311-7. PubMed ID: 20060944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preventive effect of a nonviral interferon inducer, a bacterial vaccine, on experimental influenza in mice.
    Dahl H; Degré M
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(3):467-74. PubMed ID: 4505773
    [No Abstract]   [Full Text] [Related]  

  • 50. Ribosomes as carriers for antigenic determinants of the surface of micro-organisms.
    Normier G; Pinel AM; Dussourd d'Hinterland L; Wigzell H; Binz H
    Dev Biol Stand; 1992; 77():79-85. PubMed ID: 1385236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran.
    Ebrahimi SM; Dabaghian M; Tebianian M; Jazi MH
    Virology; 2012 Aug; 430(1):63-72. PubMed ID: 22595444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Animal experiments with combined local immunization against an influenza virus disease (author's transl)].
    Raettig H; Schimmrich B
    Z Erkr Atmungsorgane; 1979 May; 153(2):250-3. PubMed ID: 44774
    [No Abstract]   [Full Text] [Related]  

  • 53. Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations.
    Riottot MM; Fournier JM; Jouin H
    Infect Immun; 1981 Jan; 31(1):71-7. PubMed ID: 7012008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
    Isaka M; Zhao Y; Nobusawa E; Nakajima S; Nakajima K; Yasuda Y; Matsui H; Hasegawa T; Maeyama J; Morokuma K; Ohkuma K; Tochikubo K
    Microbiol Immunol; 2008 Feb; 52(2):55-63. PubMed ID: 18380802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit.
    Tamura S; Samegai Y; Kurata H; Nagamine T; Aizawa C; Kurata T
    Vaccine; 1988 Oct; 6(5):409-13. PubMed ID: 2848377
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Klebsiella pneumoniae alleviates influenza-induced acute lung injury via limiting NK cell expansion.
    Wang J; Li F; Sun R; Gao X; Wei H; Tian Z
    J Immunol; 2014 Aug; 193(3):1133-41. PubMed ID: 24951819
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparative studies on the vaccination of mice with inactivated influenza virus administered by the aerosol technique, by the intranasal or intramuscular route (author's transl)].
    Neukirch M; Bauer K; Barth S
    Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):409-20. PubMed ID: 44935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant.
    Hasegawa H; Ichinohe T; Strong P; Watanabe I; Ito S; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T
    J Med Virol; 2005 Jan; 75(1):130-6. PubMed ID: 15543590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.
    Sui Z; Chen Q; Fang F; Zheng M; Chen Z
    Vaccine; 2010 Nov; 28(48):7690-8. PubMed ID: 20870054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outer membrane vesicles harboring modified lipid A moiety augment the efficacy of an influenza vaccine exhibiting reduced endotoxicity in a mouse model.
    Lee TY; Kim CU; Bae EH; Seo SH; Jeong DG; Yoon SW; Chang KT; Kim YS; Kim SH; Kim DJ
    Vaccine; 2017 Jan; 35(4):586-595. PubMed ID: 28024958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.